These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
104 related items for PubMed ID: 2867569
1. [Cobalt-activated acylase activity in patients treated with neuroleptics]. Ketner M, Kramer M, Rosnowska M. Psychiatr Pol; 1985; 19(1):30-5. PubMed ID: 2867569 [No Abstract] [Full Text] [Related]
6. [Cobalt-activated acylase activity in the serum of patients with tuberculosis treated with antitubercular agents]. Rzeszowska G, Radomińska I, Przemyska B, Modrzewska R, Szarewicz-Adamczyk W. Wiad Lek; 1986 Apr 01; 39(7):444-8. PubMed ID: 3751033 [No Abstract] [Full Text] [Related]
7. [Cobalt activated acylase in serum of patients poisoned with mushrooms]. Szczeklik A, Wiernikowski A, Musial J, Woźny E. Pol Tyg Lek; 1976 May 17; 31(20):849-51. PubMed ID: 951239 [No Abstract] [Full Text] [Related]
8. The behaviour of glycylaminopeptidase activity in the blood serum of patients with viral hepatitis and the comparison with cobalt-activated acylase activity. Szewczuk A, Barczyk-Luczykowa K, Przygodzka D. Mater Med Pol; 1978 May 17; 10(1):9-13. PubMed ID: 642597 [No Abstract] [Full Text] [Related]
9. [Value of enzyme tests in the diagnosis of toxic hepatocellular damage]. Chrostowski K, Milewski B. Pol Tyg Lek; 1974 Oct 14; 29(41):1737-40. PubMed ID: 4154060 [No Abstract] [Full Text] [Related]
10. [Difficulties of the early diagnosis of the toxic liver damage (author's transl)]. Habior A, Milewski B. Przegl Lek; 1978 Oct 14; 35(2):297-300. PubMed ID: 652996 [No Abstract] [Full Text] [Related]
11. [Review of tests for the detection of liver damage due to drugs in man]. Gielen J, Plomteux G. Ann Biol Clin (Paris); 1968 Oct 14; 26(5):741-57. PubMed ID: 4878749 [No Abstract] [Full Text] [Related]
12. Hepatotoxicity associated with phenothiazines. Jones JK, Van de Carr SW, Zimmerman H, Leroy A. Psychopharmacol Bull; 1983 Oct 14; 19(1):24-7. PubMed ID: 6131467 [No Abstract] [Full Text] [Related]
13. [Serum activity of cobalt-activated acylase in infectious mononucleosis]. Modrzewska R, Rzeszowska G, Radomińska I, Patorska-Mach E. Pol Tyg Lek; 1980 Dec 22; 35(51):2005-7. PubMed ID: 7243658 [No Abstract] [Full Text] [Related]
14. The value of gamma-glutamyl transpeptidase as a screen test for liver tumour. Aronsen KF, Nosslin B, Pihl B. Acta Chir Scand; 1970 Dec 22; 136(1):17-22. PubMed ID: 5518661 [No Abstract] [Full Text] [Related]
15. Hepatic injury associated with the phenothiazines. Clinicopathologic and follow-up study of 36 patients. Ishak KG, Irey NS. Arch Pathol; 1972 Apr 22; 93(4):283-304. PubMed ID: 5017281 [No Abstract] [Full Text] [Related]
16. Liver disease and phenothiazines. Involuntary movements. Ettinger M, Curran J. Minn Med; 1970 Jul 22; 53(7):731-6. PubMed ID: 5427683 [No Abstract] [Full Text] [Related]
18. [Possibilities of assessment of preclinical forms of toxic hepatitis by evaluating oxidase activity of mixed liver function]. Popov TA, Kaskevich LM. Vrach Delo; 1977 Mar 22; (3):126-30. PubMed ID: 855275 [No Abstract] [Full Text] [Related]
19. [Evaluation of serum glycylproline dipeptidyl aminopeptidase activity in the diagnosis of primary liver cancer]. Ye SL. Zhonghua Yi Xue Za Zhi; 1987 Mar 22; 67(3):134-6, 184. PubMed ID: 3111657 [No Abstract] [Full Text] [Related]
20. [Laboratory diagnosis of subclinical forms of chemically-induced liver damage]. Lutz W, Kralkowska E. Wiad Lek; 1986 Mar 01; 39(5):323-9. PubMed ID: 2873689 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]